| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10549-016-3726-Y |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s10549-016-3726-y |
| P932 | PMC publication ID | 4788692 |
| P698 | PubMed publication ID | 26909793 |
| P5875 | ResearchGate publication ID | 295855442 |
| P50 | author | Jack Cuzick | Q21005493 |
| Phyllis Butow | Q67471190 | ||
| Antonis C Antoniou | Q89766295 | ||
| Prue C Weideman | Q56493708 | ||
| Louise A Keogh | Q56550173 | ||
| John Hopper | Q56726496 | ||
| Emma J. Steel | Q41368475 | ||
| Kelly-Anne Phillips | Q41368487 | ||
| P2093 | author name string | Jon Emery | |
| G Bruce Mann | |||
| Alison Trainer | |||
| Mathias Bressel | |||
| Ian M Collins | |||
| Adrian Bickerstaffe | |||
| Sanjaya Maddumarachchi | |||
| Thilina Ranaweera | |||
| P2860 | cites work | Familial Risks, Early-Onset Breast Cancer, and BRCA1 and BRCA2 Germline Mutations | Q57306010 |
| Mammographic Density and the Risk and Detection of Breast Cancer | Q59545042 | ||
| Tectonic shifts in the health information economy | Q81106846 | ||
| A breast cancer prediction model incorporating familial and personal risk factors. | Q52000310 | ||
| Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. | Q53265333 | ||
| Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer | Q54089896 | ||
| 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 | Q22251112 | ||
| Prophylactic mastectomy for the prevention of breast cancer | Q24236609 | ||
| American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography | Q28295438 | ||
| A focus group study on breast cancer risk presentation: one format does not fit all | Q30541811 | ||
| Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline | Q34802964 | ||
| Online tool to guide decisions for BRCA1/2 mutation carriers | Q35808372 | ||
| Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk | Q36009831 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions | Q36615665 | ||
| Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers | Q36671223 | ||
| Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers | Q37090813 | ||
| Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre | Q37185723 | ||
| Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC) | Q37219731 | ||
| BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface | Q37507410 | ||
| Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer | Q37634207 | ||
| Assessing women at high risk of breast cancer: a review of risk assessment models | Q37739036 | ||
| BRCA and beyond: a genome-first approach to familial breast cancer risk assessment | Q37962735 | ||
| Assessing and managing breast cancer risk: clinicians' current practice and future needs | Q39164029 | ||
| Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers | Q39314538 | ||
| Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease? | Q41368391 | ||
| Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group | Q47189470 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | decision support system | Q330268 |
| P304 | page(s) | 171-182 | |
| P577 | publication date | 2016-02-24 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management | |
| P478 | volume | 156 |
| Q64115284 | 10-year performance of four models of breast cancer risk: a validation study |
| Q38930672 | A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system |
| Q92102602 | Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool |
| Q37720955 | Decision making for breast cancer prevention among women at elevated risk |
| Q96302976 | Key steps for effective breast cancer prevention |
| Q41696217 | Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review |
| Q54950358 | Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data. |
| Q58198339 | The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing |
| Q38721663 | Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries |
Search more.